David Carl Humphrey - Jun 30, 2021 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Signature
/s/ David Carl Humphrey
Stock symbol
ENSC
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 07:15 PM
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENSC Common Stock Award $0 +50K $0.00 50K Jun 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 30, 2021, pursuant to that certain Agreement and Plan of Merger, dated January 31, 2021, among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Upon completion of the Merger, the Reporting Person received a grant of 50,000 restricted stock units, which, subject generally to the Reporting Person's continued employment through each such date would vest as to 20,000 restricted stock units on December 15, 2021, an additional 15,000 restricted stock units on December 15, 2022, and an additional 15,000 restricted stock units on December 15, 2023.